Funding · Company
Kolon TissueGene, Inc.
Rockville, MDBiotech & Pharma
Kolon TissueGene, Inc. of Rockville, MD has disclosed $125M across 4 Form D offerings filed with the SEC between Dec 16, 2021 and Jun 5, 2024.
$125M
Total disclosed
4
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersRockville, MDIndustryBiotech & Pharma (Biotechnology)SEC CIK0001326507Offerings on file4
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →